161 related articles for article (PubMed ID: 37252318)
1. Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report.
Han W; Wang B; Yong X; Zhang Y; Shao M; Wang C
Pathol Oncol Res; 2023; 29():1611151. PubMed ID: 37252318
[No Abstract] [Full Text] [Related]
2. Indolent T-lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T-lymphoblastic lymphoma: case report and literature review.
Yasuda H; Tsutsui M; Ota Y; Tanaka M; Komatsu N
Histopathology; 2018 Apr; 72(5):862-866. PubMed ID: 29143359
[TBL] [Abstract][Full Text] [Related]
3. Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma-presentation in novel settings and comprehensive review of literature.
Ghezavati A; Liang CA; Mais D; Nazarullah A
J Hematop; 2023 Sep; 16(3):167-175. PubMed ID: 38175402
[TBL] [Abstract][Full Text] [Related]
4. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
[TBL] [Abstract][Full Text] [Related]
5. Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.
Ohgami RS; Arber DA; Zehnder JL; Natkunam Y; Warnke RA
Adv Anat Pathol; 2013 May; 20(3):137-40. PubMed ID: 23574769
[TBL] [Abstract][Full Text] [Related]
6. Indolent T-lymphoblastic proliferation: a report of three cases.
Yuanyuan Z; Jianlan X; Yanlin Z; Xiaoge Z
Virchows Arch; 2022 May; 480(5):1121-1126. PubMed ID: 34482472
[TBL] [Abstract][Full Text] [Related]
7. Indolent T-lymphoblastic proliferation associated with Castleman disease and low grade follicular dendric cell sarcoma: report of a case and review of literature.
Chen J; Feng J; Xiao H; Ma Q; Chen Z
Int J Clin Exp Pathol; 2019; 12(4):1497-1505. PubMed ID: 31933967
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma with immature T-cell (T-lymphoblastic) proliferation.
Eun S; Jeon YK; Jang JJ
J Korean Med Sci; 2010 Feb; 25(2):309-12. PubMed ID: 20119589
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric features of incidental indolent T lymphoblastic proliferations.
Fromm JR; Edlefsen KL; Cherian S; Wood BL; Soma L; Wu D
Cytometry B Clin Cytom; 2020 May; 98(3):282-287. PubMed ID: 31571375
[TBL] [Abstract][Full Text] [Related]
10. Indolent T-lymphblastic proliferation: report of a case involving the upper aerodigestive tract.
Yang F; Liu T; Zhao H; Hu Z; Xiao L; Liu Y; Wang X; Li Z
Int J Clin Exp Pathol; 2014; 7(9):6350-6. PubMed ID: 25337290
[TBL] [Abstract][Full Text] [Related]
11. Indolent T-lymphoblastic proliferation: A systematic review of the literature analyzing the epidemiologic, clinical, and pathologic features of 45 cases.
Saglam A; Singh K; Gollapudi S; Kumar J; Brar N; Butzmann A; Warnke R; Ohgami RS
Int J Lab Hematol; 2022 Aug; 44(4):700-711. PubMed ID: 35577551
[TBL] [Abstract][Full Text] [Related]
12. sTRBC1 and cyTRBC1 Expression Distinguishes Indolent T-Lymphoblastic Proliferations From T-Lymphoblastic Leukemia/Lymphoma.
Liu J; Li M; Fu J; Dong M; Fan X; Zhong L; Xu G; Li Y; Xi Q
Am J Surg Pathol; 2023 Nov; 47(11):1325-1331. PubMed ID: 37515427
[TBL] [Abstract][Full Text] [Related]
13. Hepatic carcinoma with indolent T-lymphoblastic proliferation (iT-LBP).
Kong M; Wang Z; Teng X; Xu L; Liu J; Jiang C; Teng L
Int J Clin Exp Pathol; 2018; 11(3):1674-1678. PubMed ID: 31938268
[TBL] [Abstract][Full Text] [Related]
14. [76-year-old patient with adenocarcinoma of the rectum and fibrolamellar hepatocellular 2d carcinoma. Case report with literature review of hepatocellular carcinoma of the fibrolamellar type].
Klimpfinger M; Jatzko G; Trink A; Samec HJ; Gaugg A
Wien Klin Wochenschr; 1987 Jul; 99(14):505-9. PubMed ID: 2820156
[TBL] [Abstract][Full Text] [Related]
15. Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease.
Kansal R; Nathwani BN; Yiakoumis X; Moschogiannis M; Sachanas S; Stefanaki K; Pangalis GA
Hum Pathol; 2015 Jul; 46(7):1057-61. PubMed ID: 25953658
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Features of Two Extremely Rare Hepatocellular Carcinoma Variants: a Brief Review of Fibrolamellar and Scirrhous Hepatocellular Carcinoma.
Samdanci ET; Akatli AN; Soylu NK
J Gastrointest Cancer; 2020 Dec; 51(4):1187-1192. PubMed ID: 32860202
[TBL] [Abstract][Full Text] [Related]
17. Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases.
Imkie M; Myers SA; Li Y; Fan F; Bennett TL; Forster J; Tawfik O
J Reprod Med; 2005 Aug; 50(8):633-7. PubMed ID: 16220774
[TBL] [Abstract][Full Text] [Related]
18. Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression.
Ohgami RS; Sendamarai AK; Atwater SK; Liedtke M; Fleming MD; Natkunam Y; Warnke RA
Am J Surg Pathol; 2014 Sep; 38(9):1298-304. PubMed ID: 24618611
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis.
Kakar S; Burgart LJ; Batts KP; Garcia J; Jain D; Ferrell LD
Mod Pathol; 2005 Nov; 18(11):1417-23. PubMed ID: 15920538
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma with indolent T-lymphoblastic proliferation.
Wang ZM; Xiao WB; Zheng SS; Sun K; Wang LJ
Leuk Lymphoma; 2006 Nov; 47(11):2424-6. PubMed ID: 17107923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
